ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

NGM NGM Biopharmaceuticals Inc

1.54
0.00 (0.00%)
시간외 거래
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
NGM Biopharmaceuticals Inc NGM 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 1.54 09:00:00
개장가 저가 고가 종가 전일 종가
1.54 1.54
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
05/04/202422:19GLOBENGM Bio Announces Closing of Tender Offer
20/03/202406:30GLOBENGM Bio to Present Two Posters Highlighting Clinical Data..
12/03/202405:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
12/03/202405:13EDGAR2Form 8-K - Current report
12/03/202405:05GLOBENGM Bio Provides Recent Business Highlights and Reports..
09/03/202407:32EDGAR2Form SC 13E3 - Going private transaction by certain issuers
09/03/202407:21EDGAR2Form SC 14D9 - Solicitation, recommendation statements
27/02/202407:11EDGAR2Form SC14D9C - Written communication relating to third party..
27/02/202407:01EDGAR2Form 8-K - Current report
26/02/202423:03GLOBENGM Bio Has Entered into a Definitive Agreement and Plan of..
21/02/202406:01GLOBENGM Bio to Participate in the Cowen 44th Annual Health Care..
15/02/202408:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/01/202420:09EDGAR2Form 8-K - Current report
19/01/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:47GLOBENGM Bio to Participate in the B. Riley Securities 4th Annual..
09/01/202422:00GLOBENGM Bio Announces New Clinical Data from Ongoing Trial of..
02/01/202421:30EDGAR2Form 8-K - Current report
05/12/202307:19EDGAR2Form 8-K - Current report
05/12/202306:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:45GLOBENGM Bio Presents Positive Phase 2b Results from the ALPINE 4..
09/11/202308:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/11/202308:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202308:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202308:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202306:05GLOBENGM Bio to Participate in Upcoming Investor Conferences
03/11/202305:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202305:06EDGAR2Form 8-K - Current report
03/11/202305:01GLOBENGM Bio Reports Third Quarter 2023 Financial Results and..
18/10/202306:28EDGAR2Form 8-K - Current report
12/10/202305:05GLOBENGM Bio Announces Oral Plenary Presentation of Data from..
27/09/202321:30PRNUSAlexandria Real Estate Equities, Inc.'s One-of-a-Kind,..
12/09/202305:01EDGAR2Form 8-K/A - Current report: [Amend]
12/08/202305:08EDGAR2Form 8-K - Current report
07/08/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
05/08/202306:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/08/202305:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
04/08/202305:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202305:07EDGAR2Form 8-K - Current report
04/08/202305:01GLOBENGM Bio Reports Second Quarter 2023 Financial Results and..
25/05/202322:00GLOBENGM Bio to Participate in Upcoming Investor Conferences
09/05/202305:05GLOBENGM Bio Announces Presentation of Data from Phase 2..
05/05/202305:05GLOBENGM Bio Reports First Quarter 2023 Financial Results and..

최근 히스토리

Delayed Upgrade Clock